274 related articles for article (PubMed ID: 35205279)
21. Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer.
Paris O; Ferraro L; Grober OM; Ravo M; De Filippo MR; Giurato G; Nassa G; Tarallo R; Cantarella C; Rizzo F; Di Benedetto A; Mottolese M; Benes V; Ambrosino C; Nola E; Weisz A
Oncogene; 2012 Sep; 31(38):4196-206. PubMed ID: 22231442
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer.
Ward A; Shukla K; Balwierz A; Soons Z; König R; Sahin O; Wiemann S
J Pathol; 2014 Aug; 233(4):368-79. PubMed ID: 24752803
[TBL] [Abstract][Full Text] [Related]
23. miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells.
Lee YM; Lee JY; Ho CC; Hong QS; Yu SL; Tzeng CR; Yang PC; Chen HW
Breast Cancer Res; 2011; 13(6):R116. PubMed ID: 22113133
[TBL] [Abstract][Full Text] [Related]
24. Involvement of Mediator complex in malignancy.
Schiano C; Casamassimi A; Rienzo M; de Nigris F; Sommese L; Napoli C
Biochim Biophys Acta; 2014 Jan; 1845(1):66-83. PubMed ID: 24342527
[TBL] [Abstract][Full Text] [Related]
25. MED1 IDR acetylation reorganizes the transcription preinitiation complex, rewires 3D chromatin interactions and reprograms gene expression.
Lin R; Barrows D; Mo Y; Onikubo T; Zhang Z; Roeder RG
bioRxiv; 2024 Mar; ():. PubMed ID: 38562677
[TBL] [Abstract][Full Text] [Related]
26. Expression of Estrogen Receptor- and Progesterone Receptor-Regulating MicroRNAs in Breast Cancer.
Kalinina T; Kononchuk V; Alekseenok E; Obukhova D; Sidorov S; Strunkin D; Gulyaeva L
Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33923732
[TBL] [Abstract][Full Text] [Related]
27. Cross-talk between HER2 and MED1 regulates tamoxifen resistance of human breast cancer cells.
Cui J; Germer K; Wu T; Wang J; Luo J; Wang SC; Wang Q; Zhang X
Cancer Res; 2012 Nov; 72(21):5625-34. PubMed ID: 22964581
[TBL] [Abstract][Full Text] [Related]
28. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer.
Liu J; Li X; Wang M; Xiao G; Yang G; Wang H; Li Y; Sun X; Qin S; Du N; Ren H; Pang Y
Int J Oncol; 2018 Oct; 53(4):1601-1612. PubMed ID: 30066905
[TBL] [Abstract][Full Text] [Related]
29. Regulation of Aurora-A kinase gene expression via GABP recruitment of TRAP220/MED1.
Udayakumar TS; Belakavadi M; Choi KH; Pandey PK; Fondell JD
J Biol Chem; 2006 May; 281(21):14691-9. PubMed ID: 16574658
[TBL] [Abstract][Full Text] [Related]
30. Loss of Estrogen-Regulated
Zhang W; Wu M; Chong QY; Zhang M; Zhang X; Hu L; Zhong Y; Qian P; Kong X; Tan S; Li G; Ding K; Lobie PE; Zhu T
Cancer Res; 2018 Sep; 78(17):4915-4928. PubMed ID: 29945962
[TBL] [Abstract][Full Text] [Related]
31. MED1 phosphorylation promotes its association with mediator: implications for nuclear receptor signaling.
Belakavadi M; Pandey PK; Vijayvargia R; Fondell JD
Mol Cell Biol; 2008 Jun; 28(12):3932-42. PubMed ID: 18391015
[TBL] [Abstract][Full Text] [Related]
32. Profiling of estrogen-regulated microRNAs in breast cancer cells.
Katchy A; Williams C
J Vis Exp; 2014 Feb; (84):e51285. PubMed ID: 24637950
[TBL] [Abstract][Full Text] [Related]
33. PHLDA1 expression is controlled by an estrogen receptor-NFκB-miR-181 regulatory loop and is essential for formation of ER+ mammospheres.
Kastrati I; Canestrari E; Frasor J
Oncogene; 2015 Apr; 34(18):2309-16. PubMed ID: 24954507
[TBL] [Abstract][Full Text] [Related]
34. Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer.
Rothé F; Ignatiadis M; Chaboteaux C; Haibe-Kains B; Kheddoumi N; Majjaj S; Badran B; Fayyad-Kazan H; Desmedt C; Harris AL; Piccart M; Sotiriou C
PLoS One; 2011; 6(6):e20980. PubMed ID: 21738599
[TBL] [Abstract][Full Text] [Related]
35. Med1 plays a critical role in the development of tamoxifen resistance.
Nagalingam A; Tighiouart M; Ryden L; Joseph L; Landberg G; Saxena NK; Sharma D
Carcinogenesis; 2012 Apr; 33(4):918-30. PubMed ID: 22345290
[TBL] [Abstract][Full Text] [Related]
36. Alternative mechanisms by which mediator subunit MED1/TRAP220 regulates peroxisome proliferator-activated receptor gamma-stimulated adipogenesis and target gene expression.
Ge K; Cho YW; Guo H; Hong TB; Guermah M; Ito M; Yu H; Kalkum M; Roeder RG
Mol Cell Biol; 2008 Feb; 28(3):1081-91. PubMed ID: 18039840
[TBL] [Abstract][Full Text] [Related]
37. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
[TBL] [Abstract][Full Text] [Related]
38. A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer.
Bastos EP; Brentani H; Pereira CA; Polpo A; Lima L; Puga RD; Pasini FS; Osorio CA; Roela RA; Achatz MI; Trapé AP; Gonzalez-Angulo AM; Brentani MM
PLoS One; 2016; 11(5):e0154325. PubMed ID: 27152840
[TBL] [Abstract][Full Text] [Related]
39. The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.
Itesako T; Seki N; Yoshino H; Chiyomaru T; Yamasaki T; Hidaka H; Yonezawa T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
PLoS One; 2014; 9(2):e84311. PubMed ID: 24520312
[TBL] [Abstract][Full Text] [Related]
40. Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer.
Switzer CH; Cheng RY; Ridnour LA; Glynn SA; Ambs S; Wink DA
Breast Cancer Res; 2012 Sep; 14(5):R125. PubMed ID: 22971289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
